Insider Transactions in Q3 2021 at Edwards Lifesciences Corp (EW)
Insider Transaction List (Q3 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 15
2021
|
Michael A Mussallem Director |
BUY
Bona fide gift
|
Indirect |
12,500
+0.39%
|
-
|
|
Sep 15
2021
|
Michael A Mussallem Director |
SELL
Open market or private sale
|
Direct |
32,550
-7.46%
|
$3,906,000
$120.91 P/Share
|
|
Sep 15
2021
|
Michael A Mussallem Director |
SELL
Bona fide gift
|
Direct |
12,500
-5.48%
|
-
|
|
Sep 15
2021
|
Michael A Mussallem Director |
BUY
Exercise of conversion of derivative security
|
Direct |
45,050
+16.2%
|
$946,050
$21.76 P/Share
|
|
Sep 10
2021
|
Larry L Wood Global President TAVR & Surg |
SELL
Open market or private sale
|
Direct |
7,830
-2.06%
|
$955,260
$122.59 P/Share
|
|
Sep 10
2021
|
Larry L Wood Global President TAVR & Surg |
BUY
Exercise of conversion of derivative security
|
Direct |
7,830
+2.02%
|
$274,050
$35.2 P/Share
|
|
Sep 10
2021
|
Donald E Bobo Jr CVP,Strategy/Corp Development |
SELL
Open market or private sale
|
Direct |
11,050
-8.23%
|
$1,348,100
$122.5 P/Share
|
|
Sep 10
2021
|
Donald E Bobo Jr CVP,Strategy/Corp Development |
BUY
Exercise of conversion of derivative security
|
Direct |
11,050
+14.08%
|
$232,050
$21.76 P/Share
|
|
Sep 08
2021
|
Catherine M. Szyman CVP, Critical Care |
SELL
Open market or private sale
|
Direct |
9,741
-26.22%
|
$1,178,661
$121.28 P/Share
|
|
Sep 08
2021
|
Catherine M. Szyman CVP, Critical Care |
BUY
Exercise of conversion of derivative security
|
Direct |
9,741
+20.77%
|
$204,561
$21.76 P/Share
|
|
Sep 08
2021
|
Huimin Wang CVP, Japan & Intercontinental |
SELL
Open market or private sale
|
Direct |
6,350
-6.08%
|
$768,350
$121.25 P/Share
|
|
Sep 08
2021
|
Huimin Wang CVP, Japan & Intercontinental |
BUY
Exercise of conversion of derivative security
|
Direct |
6,350
+5.73%
|
$133,350
$21.76 P/Share
|
|
Aug 10
2021
|
Donald E Bobo Jr CVP,Strategy/Corp Development |
SELL
Bona fide gift
|
Indirect |
7,000
-5.63%
|
-
|
|
Aug 10
2021
|
Larry L Wood Global President TAVR & Surg |
SELL
Open market or private sale
|
Direct |
7,830
-2.06%
|
$892,620
$114.14 P/Share
|
|
Aug 10
2021
|
Larry L Wood Global President TAVR & Surg |
BUY
Exercise of conversion of derivative security
|
Direct |
7,830
+2.02%
|
$274,050
$35.2 P/Share
|
|
Aug 09
2021
|
Huimin Wang CVP, Japan & Intercontinental |
SELL
Open market or private sale
|
Direct |
6,350
-6.08%
|
$730,250
$115.54 P/Share
|
|
Aug 09
2021
|
Huimin Wang CVP, Japan & Intercontinental |
BUY
Exercise of conversion of derivative security
|
Direct |
6,350
+5.73%
|
$133,350
$21.76 P/Share
|
|
Aug 06
2021
|
Donald E Bobo Jr CVP,Strategy/Corp Development |
SELL
Open market or private sale
|
Direct |
11,050
-16.38%
|
$1,259,700
$114.37 P/Share
|
|
Aug 06
2021
|
Donald E Bobo Jr CVP,Strategy/Corp Development |
BUY
Exercise of conversion of derivative security
|
Direct |
11,050
+14.08%
|
$232,050
$21.76 P/Share
|
|
Aug 05
2021
|
Catherine M. Szyman CVP, Critical Care |
SELL
Bona fide gift
|
Direct |
344
-1.24%
|
-
|
|
Aug 03
2021
|
Michael A Mussallem Director |
BUY
Bona fide gift
|
Indirect |
12,500
+0.39%
|
-
|
|
Aug 03
2021
|
Michael A Mussallem Director |
SELL
Open market or private sale
|
Direct |
32,550
-7.67%
|
$3,710,700
$114.11 P/Share
|
|
Aug 03
2021
|
Michael A Mussallem Director |
SELL
Bona fide gift
|
Direct |
12,500
-5.36%
|
-
|
|
Aug 03
2021
|
Michael A Mussallem Director |
BUY
Exercise of conversion of derivative security
|
Direct |
45,050
+16.2%
|
$946,050
$21.76 P/Share
|
|
Aug 02
2021
|
Catherine M. Szyman CVP, Critical Care |
SELL
Open market or private sale
|
Direct |
15,000
-35.08%
|
$1,695,000
$113.53 P/Share
|
|
Aug 02
2021
|
Catherine M. Szyman CVP, Critical Care |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+25.97%
|
$315,000
$21.76 P/Share
|
|
Jul 12
2021
|
Larry L Wood Global President TAVR & Surg |
SELL
Open market or private sale
|
Direct |
7,830
-2.06%
|
$837,810
$107.48 P/Share
|
|
Jul 12
2021
|
Larry L Wood Global President TAVR & Surg |
BUY
Exercise of conversion of derivative security
|
Direct |
7,830
+2.02%
|
$274,050
$35.2 P/Share
|
|
Jul 09
2021
|
Donald E Bobo Jr CVP,Strategy/Corp Development |
SELL
Open market or private sale
|
Direct |
11,050
-16.38%
|
$1,193,400
$108.15 P/Share
|
|
Jul 09
2021
|
Donald E Bobo Jr CVP,Strategy/Corp Development |
BUY
Exercise of conversion of derivative security
|
Direct |
11,050
+14.08%
|
$232,050
$21.76 P/Share
|
|
Jul 08
2021
|
Huimin Wang CVP, Japan & Intercontinental |
SELL
Open market or private sale
|
Direct |
6,350
-6.08%
|
$673,100
$106.72 P/Share
|
|
Jul 08
2021
|
Huimin Wang CVP, Japan & Intercontinental |
BUY
Exercise of conversion of derivative security
|
Direct |
6,350
+5.73%
|
$133,350
$21.76 P/Share
|
|
Jul 01
2021
|
Michael A Mussallem Director |
BUY
Bona fide gift
|
Indirect |
12,500
+0.39%
|
-
|
|
Jul 01
2021
|
Michael A Mussallem Director |
SELL
Open market or private sale
|
Direct |
32,550
-7.67%
|
$3,385,200
$104.61 P/Share
|
|
Jul 01
2021
|
Michael A Mussallem Director |
SELL
Bona fide gift
|
Direct |
12,500
-5.36%
|
-
|
|
Jul 01
2021
|
Michael A Mussallem Director |
BUY
Exercise of conversion of derivative security
|
Direct |
45,050
+16.2%
|
$946,050
$21.76 P/Share
|